Drug Trial Radar · NCT02236793
A Phase 3 Clinical Trial to Assess the Effectiveness of BioChaperone PDGF-BB In the Treatment of Chronic Diabetic Foot Ulcer
Last checked: Nov 20, 2026Latest source record: Jun 29, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
252
Actual
Start
Dec 2014
Primary completion
Aug 2016
Study completion Aug 2016
Sponsor
- Lead sponsor
- AdociaIndustry
- Sponsor type
- Industry
- Collaborators
- Virchow Group
- First posted
- Sep 11, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The present clinical trial is designed to assess the effectiveness of BioChaperone PDGF-BB applied at 4 µg/cm² every other day for up to 20 weeks and associated to Standard of Care as compared to Standard of Care alone for the treatment of neuropathic and neurovascular diabetic foot ulcers.(In order to ensure the double-blinding of the treatments, a sterile normal saline solution presented in the same multi-dose spray vials than BioChaperone PDGF-BB will be applied on patients of the control group).
Conditions
- Diabetic Foot Ulcer
Interventions
BioChaperone PDGF-BBDrug
Standard of CareOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of complete wound closure.Time frame: 20 weeks
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
B.J. Medical College and Civil Hospital
Ahmedabad, India
Dr Jivraj Mehta Smarak Health Foundation
Ahmedabad, India
Sangini Hospital
Ahmedabad, India
V.S. General Hospital & Sml NHL Municipal Medical College Sheth
Ahmedabad, India
Rajiv Gandhi Centre for Diabetes and Endocrinology
Aligarh, India
Govt Medical College and Hospital
Chandigarh, India
Sri Ramachandra Medial Centre
Chennai, India
The Madras Diabetes Research Foundation
Chennai, India
The Madras Medical Mission
Chennai, India
Gandhi Medical College & Hospital
Hyderabad, India
Nizam's Institute of Medical Sciences
Hyderabad, India
Sumana Hospital
Hyderabad, India
Surakshaka diabetic Centre(P) Ltd
Hyderabad, India
SMS Medical College & Attached Hospital
Jaipur, India
ILS Hospital
Kolkata, India
IPGME & R and SSKM Hospital
Kolkata, India
Nightingale Hospital
Kolkata, India
Rabindranath Tagore International Insitute of cardiac Sciences
Kolkata, India
Fortis Hospital Phase
Mohali, India
Seth G.S. Medical College and K.E.M Hospital
Mumbai, India
Mysore Medical College & Research Institute
Mysore, India
Govt Medical college & Hospital Medical Square
Nagpur, India
Indira Gandhi Govt Medical College and Hospital
Nagpur, India
B.J. Govt. Medical College and Sassoon Hospital
Pune, India
Inamdar Multispeciality Hospital
Pune, India
Poona Hospital & Research Centre
Pune, India
Shree Giriraj Multispeciality Hospital
Rajkot, India
King Georges Hospital
Visakhapatnam, India
Mediciti Hospital
Hyderabad, Andhra Pradesh, India
SL Raheja Hospital
Mumbai, Maharashtra, India
M.V. Hospital for Diabetes (P) Ltd
Chennai, Tamil Nadu, India
Dr V. Seshiah Diabetes Research Institute, Dr Balaji Diabetes Care centre
Chennai, Taminadu, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.